INTRODUCTION
Accepted: June 28, 1999 Purpose: Our purpose was to determine if pregnancy rates
Embryo implantation is an essential process in mam-(PRs) for hMG (human menopausal gonadotropin)-stimulated IVF-ET (in vitro ferilization-embryo transfer) can be
malian pregnancy that has recently become the focus We think that a well-developed proliferative endoCompared with the control group (n ϭ 27 cycles), the E 2 metrium should be a prerequisite for an adequate secre- supplementation of estradiol valerate starting in the early proliferative phase for a sufficient duration, followed by hMG stimulation of ovaries, can induce ade-to increase the implantation rate, which is supported general, hCG was administered at a dosage of 10,000 IU im when the presence of two or more follicles Ͼ18 by better outcomes in IVF for oocyte donation. mm in diameter were confirmed by vaginal ultrasonography. In the case that two or fewer follicles were growing, the cycle was canceled.
MATERIALS AND METHODS
Gonadotropin-releasing hormone agonist administration ended in all cycles on the day of hCG injection.
Patients
Oocyte aspiration was performed by vaginal ultrasonography under local anesthesia 34-36 hr after hCG Couples with male factors, endometriosis, ovarian factors, hormonal factors, etc., except tubal factors administration. Human tubal fluid (HTF; Irvine Scientific, Catalog were excluded from this study by the examination protocol (hysterosalphingogram, ultrasonography, horNo. 9962, USA) was used for culturing, supplemented with synthetic serum substitute (SSS; Irvine Scientific, monal assays, laparoscopy, etc.) of our laboratory. All of the women had pure tubal factor on the basis of a Catalog No. 99193) and tested in our laboratory. The medium was preserved at 4ЊC before insemination. hysterosalphingogram, which was peformed 4-5 days after menstruation, and a diagnostic laparoscopy.
Spermatozoa for insemination were prepared using the swim-up technique after samples from masturbaAll 81 patients undergoing IVF-ET at the Center for Reproductive Medicine and Infertility at Chosun tion were collected. Embryos were examined for cleavage 42-46 hr after insemination and transferred into University Hospital from June 1, 1996, to July 31, 1998, were included and randomized into two groups:
the uterine cavity at the two-to four-cell stage.
Luteal support was given in each case where an in the control group, the patients were scheduled for conventional IVF-ET programs, while estradiol valerembryo transfer took place. For luteal support, progesterone-in-oil was given intramuscularly in all of the ate was given orally to the study group from the early follicuar phase to the late luteal phase or early pregwomen from the day of oocyte retrieval, starting with a dosage of 50 mg/day, increasing to 100 mg/day from nancy.
the day of ET. Supplemental progesterone-in-oil continued until either a negative pregnancy test or sonoProtocols graphically confirmed embryonic viability was noted.
In the study group, oral estradiol valerate was given All patients were scheduled for IVF-ET using a long protocol of GnRH agonist. Nafarelen acetate (800 g/ at a dosage of 4 mg/day in addition to progesterone support during the luteal phase to the day when a day; Synarel, Searle, Korea) was given intranasally, starting on the 21st menstrual day, for pituitary desensinegative pregnancy test was noted or the day when the presence of intrauterine embryonic heart activity tization. Gonadotropin therapy was begun using the combination of hMG and follicle-stimulating hormone on transvaginal ultrasonography was detected in the case of a positive pregnancy test. Only progesterone using an established protocol.
In the control group, follicle stimulating hormone was given for luteal support in the control group. In the case of a positive pregnancy test, progesterone (FSH) (LG, Korea), 150 IU im, and hMG (LG), 150 IU im, were given daily for ovarian stimulation starting for luteal support was given until 9-12 weeks gestational age. when down-regulation was achieved (E 2 , Ͻ30 pg/ml on day 3 after uterine withdrawal bleeding) (Fig. 1) .
Biochemical pregnancy was confirmed by a serum ␤-hCG Ͼ10 IU/L. Clinical pregnancies required at In the study group, starting 3-4 days after supplementation of oral Estradiol (E 2 ) valerate (4 mg/day) had minimum the presence of a detectable gestational sac on ultrasound or the histological finding of chorionic begun, hMG, 150 IU im, and FSH, 150 IU im, were given daily. The dosage of gonadotropins was adjusted villi in the event of miscarriage or ectopic pregnancy. Ongoing pregnancies were defined by the presence of according to the individual response.
In all of the women, daily monitoring of follicular intrauterine embryonic heart activity on transvaginal ultrasonography and were either continuing or delivgrowth was generally initiated on the third or fourth day of gonadotropin therapy. Follicular monitoring was ered pregnancies at the time of this analysis. Cycle cancellation was undertaken in the event of performed with a 7.5-MHz transvaginal probe using ultrasound.
a poor response to stimulation. Data were gathered on age, days of stimulation, The timing of hCG (human chorionic gonadotropin) was based on the mean lead follicular diameter. In endometrial thickness at the time of hCG injection, number of oocytes retrieved and fertilized embryos trial thickness on the day of hCG administration was significantly higher in the study group (12.03 versus transferred, clinical pregnancies, and spontaneous abortions.
10.74 mm; P Ͻ 0.05).
Regarding ovum retrieval and IVF outcome (Tables  II and III) , the number of retrieved oocytes, the number Statistics of fertilized oocytes, and the number of transferred oocytes were higher in the control group, while the Statistical comparisons were performed by 2 analysis or Student's t test. P Ͻ 0.05 was considered number of G-sacs confirmed by transvaginal ultrasound was similar for the two groups of IVF patients. statistically significant. The data are expressed as the mean Ϯ SD.
The fertilization rate (number of fertilized oocytes/ number of retrieved oocytes) was not statistically different between the two groups (74 versus 73%; P Ͼ 0.05). But the implantation rate (number of G-sacs RESULTS confirmed by transvaginal ultrasound/number of transferred embryos) and the clinical pregnancy rate (numThe results are summarized in Tables I-III. As shown in Table I , the age distributions in the ber of pregnant cycles confirmed by ultrasound/ number of cycles where at least one embryo was transcontrol and the study groups were almost-identical, and the mean age of all patients was 32.30 years. Table ferred) in the study group were significantly higher than in the control group (26% versus 10%, P Ͻ 0.05; I also shows the data regarding ovarian response in the two groups studied.
48.3% versus 25.9%, P Ͻ 0.05). This suggests that the endometrial receptivity was increased in the study The duration of controlled ovarian hyperstimulation (COH) was not similar for the two groups of IVF group while the quality of retrieved oocytes was not patients. There were slightly more days in the study different between the two groups. group (9.86 versus 8.52 days; P Ͻ 0.01). The endome- sufficient period, which matures the endometrium adequately and increases the receptivity for embryos. This is based on higher pregnancy rates and implantation DISCUSSION rates in the study group than the control group but equal fertilization rates. Since hMG-stimulated IVF-ET was started, there has not been a significant increase in pregnancy rates Recently, vaginal ultrasonography has been used to define the endometrial thickness, which may be a despite many trials by investigators for increasing pregnancy outcomes. In past studies, the focus was on predictor for implantation (5). Gonen et al. (6) reported, in donor insemination natural cycles, that what method makes the quality of oocytes and embryos better, to increase the implantation rate. Recently, pregnancy did not occur when the endometrial thickness was Ͻ6 mm. In addition, a similar relationship improving endometrial receptivity for the embryo is becoming the main focus. But the exact mechanism of endometrial thickness to pregnancy rate has been reported following ovulation and in vitro fertilization of how the embryo implants in IVF-ET is unknown, which is the main factor for increasing pregnancy outtreatment (7-9). Others have not found any such relationship (10,11) comes; therefore, pregnancy outcomes have not changed from the past.
Previous data have suggested that improved prenancy rates (PRs) were seen in women with increased Maturation of the endometrium to receive embryos requires the proper hormonal change of estradiol and endometrial thickness as deterimined by sonography before oocyte retrieval. If poor PRs below a specific progesterone (P). Estrogen proliferates endometrial cells in the basal layer and increases progesterone minimal endometrial thickness do occur, it will be interesting to note whether any therapeutic maneuvers receptors, and progesterone induces the secretion of endometrial cells and decidualization of the stromal can improve the thickness before hCG, e.g., giving hMG therapy longer. Alternatively, in patients who do layer (3). Since estrogen priming is a prerequisite for the synthesis of P receptors in the endometrium (4), not generate an appropriate endometrial thickness, it would also be interesting to determine if the cryopresonly assuring adequate E 2 and P levels may allow proper endometrial maturation before implantation.
ervation of embryos and subsequent transfer of thawed embryos in another cycle (in which the endometrium But the hormonal changes in IVF-ET differ from those in the natural menstrual cycle. Most IVF-ETs has been primed with estrogen and progesterone after down-regulation with leuprolide acetate) may result in include the process of controlled ovarian hyperstimulation for the retrieval of many oocytes and serum E 2 is an increased PR. A randomized study to address these questions has been initiated (12) . rapidly increased by hyperstimulated follicles in a short duration. Therfore in IVF-ET, sufficient time for matuIn this study, the endometrial thickness of the study group was increased significantly more than that of ration is not given to the endometrium to receive transferred embryos, which is very different from the natural the control group (12.03 versus 10.74 mm; P Ͻ 0.05), which could be a factor that increases the pregnancy menstrual cycle and very important in this study design. It is supposed that exposure of the endomeoutcomes.
To clarify the status of the endometrium, the use of trium to a high concentration of estrogen for a short duration during controlled ovarian hyperstimulation endometrial biopsy was needed. But we evaluated the endometrium non-invasively with ultrasound. Because does not allow adequate maturation of the endometrium for implantation.
endometrial biopsies could cause endometrial injuries, the use of endometrial biopsies for evaluation of the It has been reported that IVF-ET for oocyte donation has a better outcome than conventional IVF-ET generendometrium has the risk of abortion. It is necessary that endometrial biopsies to evaluate the status of the In conclusion, supplementation of estradiol valerate from the early proliferative phase to the late secretory endometrium are used in future studies.
phase of the endometrium in hMG-stimulated IVFWhile Lewin and Smitz reported that estrogen and ET increases the receptivity of the endometrium for progesterone support during the luteal phase could not transferred embryos and clinical PRs. We think that increase the PR in IVF-ET, as Ghosh and Sengupta E 2 supplementation for a sufficient duration, starting have pointed out (13), a rise in peripherally circulating in the early proliferative phase, can induce adequate estrogen concentrations is generally observed in the proliferation and maturation of the endometrium and midluteal phase of the menstrual cycle, and this trend make the endometrium more receptible to transferred is clearly sustained in conception cycles. When the embryos, which increases the implantation rate and normal luteal-phase pattern is presumed to be defecpregnancy outcomes in IVF-ET. tive, following pituitary desensitization with GnRH
To make the conclusion clear, a more delicate design analogues in conjunction with hMG administration for of the study is necessary, such as endometrial biopsy IVF and related procedures, it is common practice to to evaluate the endometrium and serum estrogen level support the luteal phase with hCG supplementation.
assay. And the results of a third group-randomized This results in the restoration of elevated concentrato E ϩ P supplementation in the luteal phase ϩ no tions of both progesterone and estrogen in the midluteal E supplementation in the proliferative phase-would phase. However, when the alternative strategy for help ascertain if one really needs estrogen supplemenluteal support, i.e., steroid supplementation, is tation in the proliferative phase. employed, it is routine to omit the estrogen component
In this study, we did not check the serum level of and support with exogenous progesterone alone, an estrogen, did not grade the retrieved oocytes, and did approach which fails to recognize a critical role for not design a third group. Although there are a lot of estrogen during the periimplantation period. Indeed it methods to evaluate the endometrium, we performed has been demonstrated that the inclusion of estradiol only ultrasound to measure the thickness of the endovalerate during such luteal steroid supplementation metrium. In the future, further studies should be does not alter the observed implantation rate compared designed including the items pointed out to disclose to that achieved with the use of progesterone alone the cause of the increased clinical pregnancy rate. (14) .
In contrast, in women with absent or nonfunctioning ovaries undergoing ET following oocyte donation, REFERENCES exogenous progesterone and estrogen are routinely administered during and beyond the artificial luteal
